ADVANCED SOLID TUMORS
Clinical trials for ADVANCED SOLID TUMORS explained in plain language.
Never miss a new study
Get alerted when new ADVANCED SOLID TUMORS trials appear
Sign up with your email to follow new studies for ADVANCED SOLID TUMORS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Custom-Made immune cells target advanced cancers in new trial
Disease control Not yet recruitingThis is a first-in-human study to test the safety and early signs of effectiveness of a new personalized gene therapy called KXV01 for people with advanced solid tumors. The therapy involves collecting a patient's own tumor cells, identifying unique markers, and then using a modi…
Matched conditions: ADVANCED SOLID TUMORS
Phase: PHASE1 • Sponsor: TCRx Therapeutics Co.Ltd • Aim: Disease control
Last updated Apr 01, 2026 18:26 UTC
-
New 'Smart Bomb' drug trial opens for Tough-to-Treat cancers
Disease control Not yet recruitingThis study is testing a new drug called CKD-703 in people with advanced solid tumors and a specific type of lung cancer that has stopped responding to standard treatments. CKD-703 is designed to target cancer cells more precisely to try to shrink tumors while potentially causing …
Matched conditions: ADVANCED SOLID TUMORS
Phase: PHASE1, PHASE2 • Sponsor: Chong Kun Dang Pharmaceutical • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC
-
China launches major trial for rare cancer breakthroughs
Disease control Not yet recruitingThis study aims to test the safety and effectiveness of several new cancer treatments and technologies for people with advanced rare solid tumors. Researchers will use detailed molecular testing to match 600 participants with specific treatment options, including drugs, cell ther…
Matched conditions: ADVANCED SOLID TUMORS
Phase: PHASE1, PHASE2 • Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC
-
New drug duo targets tough tumors in early trial
Disease control Not yet recruitingThis early-stage study is testing a new combination of two experimental drugs, IMM2510 and IMM01, in adults with advanced solid tumors that have worsened after at least one prior treatment. The main goals are to find a safe dose and see if the combination can shrink tumors. Resea…
Matched conditions: ADVANCED SOLID TUMORS
Phase: PHASE1, PHASE2 • Sponsor: ImmuneOnco Biopharmaceuticals (Shanghai) Inc. • Aim: Disease control
Last updated Mar 31, 2026 12:12 UTC
-
New drug combo tested in fight against advanced cancers
Disease control Not yet recruitingThis study is testing an experimental drug called QLS5132, given by IV in combination with other cancer therapies, for people with advanced solid tumors like lung, stomach, ovarian, and endometrial cancer. The main goals are to find a safe and effective dose and to see how well t…
Matched conditions: ADVANCED SOLID TUMORS
Phase: PHASE1, PHASE2 • Sponsor: Qilu Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC
-
New cell injection tested for Tough-to-Treat cancers
Disease control Not yet recruitingThis is a very early study to check the safety and initial effects of an experimental cell therapy called GK01. It will involve 10 adults with advanced solid tumors that have progressed despite standard treatments. The main goal is to see if the treatment is safe and how the body…
Matched conditions: ADVANCED SOLID TUMORS
Phase: EARLY_PHASE1 • Sponsor: Beijing Geekgene Technology Co., LTD • Aim: Disease control
Last updated Mar 30, 2026 14:35 UTC
-
New hope drug enters human testing for Tough-to-Treat cancers
Disease control Not yet recruitingThis is an early-stage study to test a new drug called SKB103 for people with advanced solid tumors that have stopped responding to standard treatments. The main goals are to find a safe dose, see how the body processes the drug, and look for early signs that it might help shrink…
Matched conditions: ADVANCED SOLID TUMORS
Phase: PHASE1, PHASE2 • Sponsor: Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. • Aim: Disease control
Last updated Mar 27, 2026 12:40 UTC
-
Experimental cell therapy trial opens for advanced cancer patients
Disease control Not yet recruitingThis early-stage study is testing a new cell therapy called GK01 in patients with advanced solid tumors who have run out of standard treatment options. Researchers will give 15 participants injections of their own modified immune cells to see if the treatment is safe and what dos…
Matched conditions: ADVANCED SOLID TUMORS
Phase: PHASE1 • Sponsor: Beijing Geekgene Technology Co., LTD • Aim: Disease control
Last updated Mar 25, 2026 14:08 UTC
-
New hope for tough cancers: experimental drug targets key mutation
Disease control Not yet recruitingThis study is testing a new oral drug called BPI-572270 for people with advanced cancers that have specific RAS genetic mutations. Researchers want to find the safest and most effective dose, and see if it helps control cancers like lung, colorectal, and pancreatic cancer that ha…
Matched conditions: ADVANCED SOLID TUMORS
Phase: PHASE1, PHASE2 • Sponsor: Betta Pharmaceuticals Co., Ltd. • Aim: Disease control
Last updated Mar 25, 2026 14:07 UTC
-
Custom-Made immune cells tested as new weapon against tough cancers
Disease control Not yet recruitingThis is a first-in-human study to test the safety and early signs of effectiveness of a new, personalized gene therapy called KXV01 for people with advanced solid tumors. The therapy involves collecting a patient's own tumor-fighting immune cells, modifying them with a virus to b…
Matched conditions: ADVANCED SOLID TUMORS
Phase: PHASE1 • Sponsor: The First Hospital of Jilin University • Aim: Disease control
Last updated Mar 24, 2026 12:02 UTC
-
Cancer patients get chance to continue promising treatment
Disease control Not yet recruitingThis study allows cancer patients who are already benefiting from RVU120 treatment in a previous trial to continue receiving it. It aims to monitor safety and track how long patients can stay on the treatment. Only 10 participants who show continued benefit and cannot access stan…
Matched conditions: ADVANCED SOLID TUMORS
Phase: PHASE2 • Sponsor: Ryvu Therapeutics SA • Aim: Disease control
Last updated Mar 24, 2026 12:01 UTC
-
New 'Smart Bomb' drug targets Hard-to-Treat cancers
Disease control Not yet recruitingThis study is testing a new drug called LCB02A for people with advanced solid tumors that have a specific protein marker called CLDN18.2. The main goals are to find a safe and effective dose and to see if the drug can shrink tumors. It is for people whose cancer has not responded…
Matched conditions: ADVANCED SOLID TUMORS
Phase: PHASE1, PHASE2 • Sponsor: LigaChem Biosciences, Inc. • Aim: Disease control
Last updated Mar 23, 2026 15:18 UTC
-
Personalized immune cells fight advanced cancers in new trial
Disease control Not yet recruitingThis study is testing a personalized immune cell therapy for people with advanced lung, liver, colorectal, or breast cancer. Doctors take a patient's own blood cells, grow and activate immune cells in a lab, and then infuse them back into the patient to help the body's immune sys…
Matched conditions: ADVANCED SOLID TUMORS
Phase: PHASE1, PHASE2 • Sponsor: Liaoning Medical Diagnosis and Treatment Technology Research and Development Co., Ltd. • Aim: Disease control
Last updated Mar 20, 2026 14:48 UTC
-
New hope drug enters human testing for Tough-to-Treat cancers
Disease control Not yet recruitingThis early-stage study is testing a new drug called XNW34017 in people with advanced solid tumors that have stopped responding to standard treatments. The main goals are to find a safe dose and see if the drug shows any signs of fighting the cancer. The study will enroll about 15…
Matched conditions: ADVANCED SOLID TUMORS
Phase: PHASE1, PHASE2 • Sponsor: Evopoint Biosciences Inc. • Aim: Disease control
Last updated Mar 17, 2026 13:09 UTC
-
Scientists test Immune-Boosting combo in fight against tough cancers
Disease control Not yet recruitingThis early-stage study is testing the safety and initial effectiveness of combining two drugs—peginterferon alfa-2b and an anti-PD-1 antibody—in people with advanced solid tumors that have spread or are hard to treat. The main goal is to find the highest dose patients can tolerat…
Matched conditions: ADVANCED SOLID TUMORS
Phase: NA • Sponsor: The First Affiliated Hospital of Xiamen University • Aim: Disease control
Last updated Mar 12, 2026 13:51 UTC
-
New cancer drug enters first human testing
Disease control Not yet recruitingThis is the first human study of an experimental cancer drug called BGM-2121. Researchers will test it in 35 adults with advanced solid tumors who have already tried standard treatments. The main goals are to find the safest dose and see how the body handles the drug, while also …
Matched conditions: ADVANCED SOLID TUMORS
Phase: PHASE1 • Sponsor: BioGate Precision Medicine Corp. • Aim: Disease control
Last updated Mar 11, 2026 14:53 UTC
-
New cancer drug begins first human testing
Disease control Not yet recruitingThis is a first-in-human study testing a new drug called HWS116 in patients with advanced solid tumors who have no standard treatments left. The study will first find the safest dose and then test how well the drug might work against cancers like colorectal, gastric, and pancreat…
Matched conditions: ADVANCED SOLID TUMORS
Phase: PHASE1 • Sponsor: Wuhan Humanwell Innovative Drug Research and Development Center Limited Company • Aim: Disease control
Last updated Mar 05, 2026 13:59 UTC
-
New hope for tough cancers: early trial tests novel drug
Disease control Not yet recruitingThis study is testing a new drug called SKB105 for people with advanced solid tumors that have stopped responding to standard treatments. The main goals are to find a safe dose and see if the drug can shrink tumors. It will involve about 256 adult participants who have no other g…
Matched conditions: ADVANCED SOLID TUMORS
Phase: PHASE1, PHASE2 • Sponsor: Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. • Aim: Disease control
Last updated Mar 02, 2026 15:22 UTC
-
New targeted cancer therapy begins first human testing
Disease control Not yet recruitingThis is the first human study of an experimental cancer drug called M7437, which targets a specific protein found on certain tumor cells. The study will test the safety, side effects, and early effectiveness of M7437 in 138 people with advanced solid tumors that have stopped resp…
Matched conditions: ADVANCED SOLID TUMORS
Phase: PHASE1 • Sponsor: Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany • Aim: Disease control
Last updated Jan 26, 2026 13:59 UTC